Literature DB >> 14611921

Women have later onset than men in schizophrenia--but only in its paranoid form. Results of the DSP project.

Raimo K R Salokangas1, Teija Honkonen, Soile Saarinen.   

Abstract

According to the literature, schizophrenia begins in men earlier than in women. It has been argued that the gender-bound age difference is due to the protective antidopaminergic effect of estrogens in women. However, the effect of gender on the age of onset may vary between different types of schizophrenias, and can also be modulated by marital status and by age at onset of illness. Comprehensive data were collected on 3306 DSM IIR schizophrenia patients, aged 15-64 years, who had been discharged from psychiatric hospitals in Finland in 1982, 1986 and 1990. The age of onset of illness (AOI) was defined by the age at the first admission (AFA). Male patients were admitted earlier than female patients, and a small second peak in women appeared at the age of 40-44. However, there were no gender differences in AFA within diagnostic subgroups, except in paranoid schizophrenia in which AFA was lower in men than in women even when marital status was taken into account. Within paranoid schizophrenia, this effect of gender was significant only in those of the patients whose AFA was higher than 30 years. It is suggested that there is no gender difference in AOI in early onset schizophrenia. In later onset, paranoid schizophrenia, the illness seems to manifest in women later than in men.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611921     DOI: 10.1016/j.eurpsy.2003.03.001

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  6 in total

1.  Gender differences in the prediction of 5-year outcome in first episode psychosis.

Authors:  Maria Mattsson; Lena Flyckt; Gunnar Edman; Håkan Nyman; Johan Cullberg; Yvonne Forsell
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

2.  Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder.

Authors:  Rachael K Willhite; Tara A Niendam; Carrie E Bearden; Jamie Zinberg; Mary P O'Brien; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2008-06-24       Impact factor: 4.939

3.  What do individuals with schizophrenia need to increase their well-being.

Authors:  Petra Gunnmo; Helena Fatouros Bergman
Journal:  Int J Qual Stud Health Well-being       Date:  2011-02-14

4.  Psychosis risk as a function of age at onset: a comparison between early- and late-onset psychosis in a general population sample.

Authors:  Sebastian Köhler; Jim van Os; Ron de Graaf; Wilma Vollebergh; Frans Verhey; Lydia Krabbendam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-03-12       Impact factor: 4.328

5.  Empirical support for DSM-IV schizoaffective disorder: clinical and cognitive validators from a large patient sample.

Authors:  Pamela DeRosse; Katherine E Burdick; Todd Lencz; Samuel G Siris; Anil K Malhotra
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

Review 6.  Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.